• Viewed 10,240 times by 3014 users (Last 30 days)
  • print Created with Sketch. Print
TOX
Click for more information
0.00% $2.84

TOX FREE SOLUTIONS LIMITED - Announcements

Currently unlisted. watchlist Created with Sketch. Add to my watchlist

Corporate Spotlight
Not Yet Available

Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.

Claim your IR profile arrow Created with Sketch.
See benefits

Announcements


Plus500
Plus500
ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
TRADE NOW
TRADE NOW
Plus500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
TRADE NOW

Filter Results
All Price Sensitive Only
search Created with Sketch. Search
search Created with Sketch. Search
TOX Removal from Official List28/05/18 download Created with Sketch. 219.6KB
TOX Appendix 3Z - R Allen25/05/18 download Created with Sketch. 19.53KB
TOX Appendix 3Z - M Humphris25/05/18 download Created with Sketch. 19.54KB
TOX Appendix 3Z - K Hirschfeld25/05/18 download Created with Sketch. 19.53KB
TOX Appendix 3Z - B McKinnon25/05/18 download Created with Sketch. 19.52KB
TOX Appendix 3Z - S Gostlow25/05/18 download Created with Sketch. 19.52KB
TOX CWY: Completion of acquisition of Tox Free Solutions Limited25/05/18 download Created with Sketch. 746.3KB
TOX Implementation of Scheme of ArrangementPRICE SENSITIVE25/05/18 download Created with Sketch. 234.69KB
TOX Ceasing to be a substantial holder16/05/18
TOX Appendix 3Y - Steve Gostlow11/05/18
TOX Appendix 3B11/05/18
TOX Suspension from Official Quotation (COT 11/5/18)PRICE SENSITIVE11/05/18
TOX CWY: Toxfree Scheme of Arrangement becomes effective11/05/18
TOX Scheme of Arrangement Becomes EffectivePRICE SENSITIVE11/05/18
TOX Dividend/Distribution - TOXPRICE SENSITIVE10/05/18
TOX CWY: Federal Court approves Toxfree Scheme of Arrangement10/05/18
TOX Federal Court Approves Scheme of ArrangementPRICE SENSITIVE10/05/18
TOX Results of Scheme Meeting03/05/18
TOX Scheme Meeting Chairman's Address - 3 May 201803/05/18
TOX ACCC Not To Oppose Scheme of Arrangement26/04/18
TOX CWY: ACCC Approves Acquisition of Tox Free26/04/18
TOX ACCC will not oppose Cleanaway's acqusition of Tox FreePRICE SENSITIVE26/04/18
TOX Scheme Meeting date postponed28/03/18
TOX CWY: Tox Free Acquisition Timetable Update23/03/18
TOX Update on Timetable for Scheme of ArrangementPRICE SENSITIVE23/03/18
TOX Federal Court Orders Convening of Scheme MeetingPRICE SENSITIVE02/03/18
TOX First Half FY18 Results Presentation15/02/18
TOX Dividend/Distribution - TOX15/02/18
TOX Interim report and appendix 4(D)PRICE SENSITIVE15/02/18
TOX Update on Timetable for Scheme of Arrangement01/02/18
TOX Satisfaction of Institutional Offer Condition PrecedentPRICE SENSITIVE21/12/17
TOX Ceasing to be a substantial holder15/12/17
TOX Change in substantial holding14/12/17
TOX Change in substantial holding13/12/17
TOX Tox Suspends Dividend Reinvestment Plan11/12/17
TOX CWY:Investor Presentation- Acquisition of Tox Free Solutions11/12/17
TOX CWY: Acquisition of Tox Free Solutions and Equity RaisingPRICE SENSITIVE11/12/17
TOX Tox Free Solutions Recommended Transaction with CleanawayPRICE SENSITIVE11/12/17
TOX CWY: Scheme Implementation Deed between Cleanaway and ToxPRICE SENSITIVE11/12/17
TOX Appendix 3Y - Steve Gostlow - 22 November 201722/11/17
TOX Results of Annual General Meeting - 22 Nov 201722/11/17
TOX 2017 AGM Chairman's Address and MD Presentation22/11/17
TOX Ceasing to be a substantial holder from CGF17/11/17
TOX UBS Australasia Conference 2017PRICE SENSITIVE14/11/17
TOX Ceasing to be a substantial holder08/11/17
TOX Dispatch of 2017 Annual Report & Notice of AGM20/10/17
TOX Appendix 3B06/10/17
TOX Corporate Governance Statement 30 June 201703/10/17
TOX Update - Dividend/Distribution - TOX15/09/17
TOX Appendix 3Y Steve Gostlow - 11 September 201712/09/17
TOX Appendix 4G30/08/17
TOX Dividend/Distribution - TOX30/08/17
TOX Financial Year 2017 Results Presentation30/08/17
TOX Financial Year 2017 Annual Report30/08/17
TOX Appendix 4E and FY17 results commentaryPRICE SENSITIVE30/08/17
TOX Morgan Stanley Conference PresentationPRICE SENSITIVE15/06/17
TOX Strategic Transaction with JJ RichardsPRICE SENSITIVE01/06/17
TOX Results of General Meeting - 24 May 201724/05/17
TOX Change of Registered Office Address15/05/17
TOX Investor Tour Day 2 Presentation10/05/17
TOX Investor Tour Day 1 Presentation09/05/17
TOX Investor Day Strategy Presentation09/05/17
TOX Notice of General Meeting - 21-Apr-1721/04/17
TOX Appendix 3Y Robert McKinnon - 30 Mar 201730/03/17
TOX Appendix 3Y Katherine Hirschfeld - 30 Mar 201730/03/17
TOX Daniels - Payment of Deferred Consideration30/03/17
TOX Appendix 3B - 28 March 201728/03/17
TOX Update on Waste Services ContractPRICE SENSITIVE28/03/17
TOX Trading Halt Request24/03/17
TOX Trading HaltPRICE SENSITIVE24/03/17
TOX Update - Dividend/Distribution - TOX10/03/17
TOX FY17 Half Year Results Presentation23/02/17
TOX Dividend/Distribution - TOX23/02/17
TOX Interim Report and Appendix 4DPRICE SENSITIVE23/02/17
TOX Becoming a substantial holder15/12/16
TOX Becoming a substantial holder from CGF15/12/16
TOX Tox Free Solutions - Change of Address09/12/16
TOX Ceasing to be a substantial holder from CGF08/12/16
TOX Ceasing to be a substantial holder08/12/16
TOX Ceasing to be a substantial holder from NAB08/12/16
TOX Becoming a substantial holder07/12/16
TOX Change in substantial holding06/12/16
TOX Becoming a substantial holder02/12/16
TOX Appendix 3B - 1 December 201601/12/16
TOX Completion of Acquisition of Daniels Health Australia01/12/16
TOX Becoming a substantial holder from CGF30/11/16
TOX Becoming a substantial holder30/11/16
TOX Results of Annual General Meeting - 30 Nov 201630/11/16
TOX 2016 AGM Chairman's Address and MD Presentation30/11/16
TOX Appendix 3Y - Steve Gostlow29/11/16
TOX Appendix 3Y - Richard Allen29/11/16
TOX Appendix 3Y - Michael Humphris29/11/16
TOX Appendix 3Y - Katherine Hirschfeld29/11/16
TOX Appendix 3Y - Robert McKinnon29/11/16
TOX Close of Retail Entitlement Offer23/11/16
TOX Becoming a substantial holder - NAB14/11/16
TOX Change in substantial holding11/11/16
TOX Change in substantial holding11/11/16
TOX Ceasing to be a substantial holder from NAB10/11/16
TOX UBS Australasia Conference Presentation08/11/16
TOX Removal from Official List
28/05/18 download Created with Sketch. 219.6KB
TOX Appendix 3Z - R Allen
25/05/18 download Created with Sketch. 19.53KB
TOX Appendix 3Z - M Humphris
25/05/18 download Created with Sketch. 19.54KB
TOX Appendix 3Z - K Hirschfeld
25/05/18 download Created with Sketch. 19.53KB
TOX Appendix 3Z - B McKinnon
25/05/18 download Created with Sketch. 19.52KB
TOX Appendix 3Z - S Gostlow
25/05/18 download Created with Sketch. 19.52KB
TOX CWY: Completion of acquisition of Tox Free Solutions Limited
25/05/18 download Created with Sketch. 746.3KB
TOX Implementation of Scheme of Arrangement
25/05/18PRICE SENSITIVE download Created with Sketch. 234.69KB
TOX Ceasing to be a substantial holder
16/05/18
TOX Appendix 3Y - Steve Gostlow
11/05/18
TOX Appendix 3B
11/05/18
TOX Suspension from Official Quotation (COT 11/5/18)
11/05/18PRICE SENSITIVE
TOX CWY: Toxfree Scheme of Arrangement becomes effective
11/05/18
TOX Scheme of Arrangement Becomes Effective
11/05/18PRICE SENSITIVE
TOX Dividend/Distribution - TOX
10/05/18PRICE SENSITIVE
TOX CWY: Federal Court approves Toxfree Scheme of Arrangement
10/05/18
TOX Federal Court Approves Scheme of Arrangement
10/05/18PRICE SENSITIVE
TOX Results of Scheme Meeting
03/05/18
TOX Scheme Meeting Chairman's Address - 3 May 2018
03/05/18
TOX ACCC Not To Oppose Scheme of Arrangement
26/04/18
TOX CWY: ACCC Approves Acquisition of Tox Free
26/04/18
TOX ACCC will not oppose Cleanaway's acqusition of Tox Free
26/04/18PRICE SENSITIVE
TOX Scheme Meeting date postponed
28/03/18
TOX CWY: Tox Free Acquisition Timetable Update
23/03/18
TOX Update on Timetable for Scheme of Arrangement
23/03/18PRICE SENSITIVE
TOX Federal Court Orders Convening of Scheme Meeting
02/03/18PRICE SENSITIVE
TOX First Half FY18 Results Presentation
15/02/18
TOX Dividend/Distribution - TOX
15/02/18
TOX Interim report and appendix 4(D)
15/02/18PRICE SENSITIVE
TOX Update on Timetable for Scheme of Arrangement
01/02/18
TOX Satisfaction of Institutional Offer Condition Precedent
21/12/17PRICE SENSITIVE
TOX Ceasing to be a substantial holder
15/12/17
TOX Change in substantial holding
14/12/17
TOX Change in substantial holding
13/12/17
TOX Tox Suspends Dividend Reinvestment Plan
11/12/17
TOX CWY:Investor Presentation- Acquisition of Tox Free Solutions
11/12/17
TOX CWY: Acquisition of Tox Free Solutions and Equity Raising
11/12/17PRICE SENSITIVE
TOX Tox Free Solutions Recommended Transaction with Cleanaway
11/12/17PRICE SENSITIVE
TOX CWY: Scheme Implementation Deed between Cleanaway and Tox
11/12/17PRICE SENSITIVE
TOX Appendix 3Y - Steve Gostlow - 22 November 2017
22/11/17
TOX Results of Annual General Meeting - 22 Nov 2017
22/11/17
TOX 2017 AGM Chairman's Address and MD Presentation
22/11/17
TOX Ceasing to be a substantial holder from CGF
17/11/17
TOX UBS Australasia Conference 2017
14/11/17PRICE SENSITIVE
TOX Ceasing to be a substantial holder
08/11/17
TOX Dispatch of 2017 Annual Report & Notice of AGM
20/10/17
TOX Appendix 3B
06/10/17
TOX Corporate Governance Statement 30 June 2017
03/10/17
TOX Update - Dividend/Distribution - TOX
15/09/17
TOX Appendix 3Y Steve Gostlow - 11 September 2017
12/09/17
TOX Appendix 4G
30/08/17
TOX Dividend/Distribution - TOX
30/08/17
TOX Financial Year 2017 Results Presentation
30/08/17
TOX Financial Year 2017 Annual Report
30/08/17
TOX Appendix 4E and FY17 results commentary
30/08/17PRICE SENSITIVE
TOX Morgan Stanley Conference Presentation
15/06/17PRICE SENSITIVE
TOX Strategic Transaction with JJ Richards
01/06/17PRICE SENSITIVE
TOX Results of General Meeting - 24 May 2017
24/05/17
TOX Change of Registered Office Address
15/05/17
TOX Investor Tour Day 2 Presentation
10/05/17
TOX Investor Tour Day 1 Presentation
09/05/17
TOX Investor Day Strategy Presentation
09/05/17
TOX Notice of General Meeting - 21-Apr-17
21/04/17
TOX Appendix 3Y Robert McKinnon - 30 Mar 2017
30/03/17
TOX Appendix 3Y Katherine Hirschfeld - 30 Mar 2017
30/03/17
TOX Daniels - Payment of Deferred Consideration
30/03/17
TOX Appendix 3B - 28 March 2017
28/03/17
TOX Update on Waste Services Contract
28/03/17PRICE SENSITIVE
TOX Trading Halt Request
24/03/17
TOX Trading Halt
24/03/17PRICE SENSITIVE
TOX Update - Dividend/Distribution - TOX
10/03/17
TOX FY17 Half Year Results Presentation
23/02/17
TOX Dividend/Distribution - TOX
23/02/17
TOX Interim Report and Appendix 4D
23/02/17PRICE SENSITIVE
TOX Becoming a substantial holder
15/12/16
TOX Becoming a substantial holder from CGF
15/12/16
TOX Tox Free Solutions - Change of Address
09/12/16
TOX Ceasing to be a substantial holder from CGF
08/12/16
TOX Ceasing to be a substantial holder
08/12/16
TOX Ceasing to be a substantial holder from NAB
08/12/16
TOX Becoming a substantial holder
07/12/16
TOX Change in substantial holding
06/12/16
TOX Becoming a substantial holder
02/12/16
TOX Appendix 3B - 1 December 2016
01/12/16
TOX Completion of Acquisition of Daniels Health Australia
01/12/16
TOX Becoming a substantial holder from CGF
30/11/16
TOX Becoming a substantial holder
30/11/16
TOX Results of Annual General Meeting - 30 Nov 2016
30/11/16
TOX 2016 AGM Chairman's Address and MD Presentation
30/11/16
TOX Appendix 3Y - Steve Gostlow
29/11/16
TOX Appendix 3Y - Richard Allen
29/11/16
TOX Appendix 3Y - Michael Humphris
29/11/16
TOX Appendix 3Y - Katherine Hirschfeld
29/11/16
TOX Appendix 3Y - Robert McKinnon
29/11/16
TOX Close of Retail Entitlement Offer
23/11/16
TOX Becoming a substantial holder - NAB
14/11/16
TOX Change in substantial holding
11/11/16
TOX Change in substantial holding
11/11/16
TOX Ceasing to be a substantial holder from NAB
10/11/16
TOX UBS Australasia Conference Presentation
08/11/16
refresh Created with Sketch. REFRESH
 

Top Stories

Banshee's historic trenches prove rich in antimony and gold for GDM

Great Divide Mining Ltd has found high-grade antimony and gold through geochemical sampling at its Banshee prospect in Queensland
HotCopper Highlights: Your most watched stocks for Week 46, 2024 What you - HotCopper users - were most interested in viewing and discussing this week (Week 46 of the year!)
InhaleRX gains approval for clinical trial to test non-opioid therapy for cancer pain InhaleRX Ltd has received approval for a Phase 2 clinical trial to test its novel therapy IRX-211 for treatment of Breakthrough Cancer Pain
NT Gov't delivers environmental approval for Empire Energy's Beetaloo Carpentaria pilot gas play Empire Energy (ASX:EEG) has confirmed the NT government has delivered environmental approvals for Carpentaria.
CuFe sells its Crossroads gold royalty to Northern Star for $4M cash; says better than waiting for mine launch CuFe Ltd (ASX:CUF) has decided not to wait around for Northern Star's Crossroads mine to get up and running, selling its $4M royalty right.
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.